Bimodal inhibition of caspase-1 by aryloxymethyl and acyloxymethyl ketones

被引:22
作者
Brady, KD [1 ]
机构
[1] BASF Biores Corp, Worcester, MA 01605 USA
关键词
D O I
10.1021/bi9803325
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The caspase-1 (interleukin 1 beta-converting enzyme; ICE) titrant 3-[2-(2-benzyloxycarbonylamino-3-methylbutyrylamino)propionylamino]-4-oxo-5-(2-oxo-2H-chromen-7-yloxy)pentanoic acid (1(Dang, L. C., et al. (1996) Biochemistry 35, 14910-14916)) inhibits caspase-1 activity rapidly, while release of the 7-hydroxycoumarin fluorophore is much slower. Progress curve analysis of land of the related acyloxymethyl ketone 3-[2-(2-benzyloxycarbonylamino-3-methylbutyrylamino)propionylamino]4-oxo-5-(1-oxo-3-phenylpropoxy)pentanoic acid (2) identifies distinctive residual patterns which are caused by the superimposition of potent slow-binding reversible inhibition with slower, irreversible inactivation. Standard kinetic models are not entirely adequate for analysis of these bimodal inhibitors, but by measuring the kinetic properties of these inhibitors by several independent techniques and comparing these to simulations which closely mimic the inhibitor actions, careful. application of the standard models can provide reasonably accurate kinetic constants.
引用
收藏
页码:8508 / 8515
页数:8
相关论文
共 32 条
  • [1] BROMME D, 1994, BIOL CHEM HOPPESEYLE, V374, P343
  • [2] TIGHT-BINDING INHIBITORS .1. KINETIC-BEHAVIOR
    CHA, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1975, 24 (23) : 2177 - 2185
  • [3] Preparation of an autolysis-resistant interleukin-1 beta converting enzyme mutant
    Dang, LC
    Talanian, RV
    Banach, D
    Hackett, MC
    Gilmore, JL
    Hays, SJ
    Mankovich, JA
    Brady, KD
    [J]. BIOCHEMISTRY, 1996, 35 (47) : 14910 - 14916
  • [4] Pyridazinodiazepines as a high-affinity, P-2-P-3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor
    Dolle, RE
    Prasad, CVC
    Prouty, CP
    Salvino, JM
    Awad, MMA
    Schmidt, SJ
    Hoyer, D
    Ross, TM
    Graybill, TL
    Speier, GJ
    Uhl, J
    Miller, BE
    Helaszek, CT
    Ator, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (13) : 1941 - 1946
  • [5] ASPARTYL ALPHA-((1-PHENYL-3-(TRIFLUOROMETHYL)PYRAZOL-5-YL)OXY)METHYL KETONES AS INTERLEUKIN-1-BETA CONVERTING-ENZYME INHIBITORS - SIGNIFICANCE OF THE P-1 AND P-3 AMIDO NITROGENS FOR ENZYME-PEPTIDE INHIBITOR BINDING
    DOLLE, RE
    SINGH, J
    RINKER, J
    HOYER, D
    PRASAD, CVC
    GRAYBILL, TL
    SALVINO, JM
    HELASZEK, CT
    MILLER, RE
    ATOR, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (23) : 3863 - 3866
  • [6] ASPARTYL ALPHA-((DIPHENYLPHOSPHINYL)OXY)METHYL KETONES AS NOVEL INHIBITORS OF INTERLEUKIN-1-BETA CONVERTING-ENZYME - UTILITY OF THE DIPHENYLPHOSPHINIC ACID LEAVING GROUP FOR THE INHIBITION OF CYSTEINE PROTEASES
    DOLLE, RE
    SINGH, J
    WHIPPLE, D
    OSIFO, IK
    SPEIER, G
    GRAYBILL, TL
    GREGORY, JS
    HARRIS, AL
    HELASZEK, CT
    MILLER, RE
    ATOR, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) : 220 - 222
  • [7] P-1 ASPARTATE-BASED PEPTIDE ALPHA-((2,6-DICHLOROBENZOYL)OXY)METHYL KETONES AS POTENT TIME-DEPENDENT INHIBITORS OF INTERLEUKIN-1-BETA-CONVERTING ENZYME
    DOLLE, RE
    HOYER, D
    PRASAD, CVC
    SCHMIDT, SJ
    HELASZEK, CT
    MILLER, RE
    ATOR, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) : 563 - 564
  • [8] Estrov Z, 1996, DRUG NEWS PERSPECT, V9, P5
  • [9] Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production
    Ghayur, T
    Banerjee, S
    Hugunin, M
    Butler, D
    Herzog, L
    Carter, A
    Quintal, L
    Sekut, L
    Talanian, R
    Paskind, M
    Wong, W
    Kamen, R
    Tracey, D
    Allen, H
    [J]. NATURE, 1997, 386 (6625) : 619 - 623
  • [10] Giegel DA, 1997, J CELL BIOCHEM, V64, P11